Evaluating The Annual Cost Per Response Rate of Pirfenidone And Nintedanib For The Treatment of Patients With Idiopathic Pulmonary Fibrosis
Autor: | A. Skroumpelos, L Papageorgiou, K Samara, X Caporis |
---|---|
Rok vydání: | 2017 |
Předmět: |
Response rate (survey)
medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Pirfenidone medicine.disease Gastroenterology Idiopathic pulmonary fibrosis chemistry.chemical_compound chemistry Internal medicine Physical therapy Medicine Nintedanib business medicine.drug |
Zdroj: | Value in Health. 20:A642 |
ISSN: | 1098-3015 |
Databáze: | OpenAIRE |
Externí odkaz: |